BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8394726)

  • 1. [Migraine, serotonin and serotonergic receptors].
    Pascual J
    Neurologia; 1993; 8(6):180-3. PubMed ID: 8394726
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs].
    Amelin AV; Skoromets AA; Ignatov IuD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(7):55-8. PubMed ID: 10957805
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical implication of microdialysis findings.
    Deakin JF; Graeff FG; Guimaraes FS
    Trends Pharmacol Sci; 1993 Jul; 14(7):263. PubMed ID: 8129813
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.
    Blier P; Szabo ST
    J Clin Psychiatry; 2005; 66 Suppl 8():30-40. PubMed ID: 16336034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of phencyclidine metabolites on serotonin uptake in rat brain.
    Hori T; Suzuki T; Baba A; Abe S; Yamamoto T; Moroji T; Shiraishi H
    Neurosci Lett; 1996 May; 209(3):153-6. PubMed ID: 8736633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic regulation of noradrenergic coerulean neurons: electrophysiological evidence for the involvement of 5-HT2 receptors.
    Gorea E; Adrien J
    Eur J Pharmacol; 1988 Sep; 154(3):285-91. PubMed ID: 3234483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man.
    Larisch R; Klimke A; Hamacher K; Henning U; Estalji S; Hohlfeld T; Vosberg H; Tosch M; Gaebel W; Coenen HH; Müller-Gärtner HW
    Behav Brain Res; 2003 Feb; 139(1-2):21-9. PubMed ID: 12642173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [5-HT receptors. Significant target group in the treatment of migraine].
    Dahlöf C; Edvinsson L
    Lakartidningen; 1993 Feb; 90(7):569-74. PubMed ID: 8437466
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet 3H ketanserin binding in migraine.
    Shukla R; Khanna VK; Pradeep S; Husain M; Tandon R; Nag D; Dikshit M; Srimal RC; Seth PK
    Cephalalgia; 2001 Jun; 21(5):567-72. PubMed ID: 11472383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and biochemical changes of the serotonergic system in migraine pathobiology.
    Gasparini CF; Smith RA; Griffiths LR
    J Headache Pain; 2017 Dec; 18(1):20. PubMed ID: 28194570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of experimental hypothyroidism on 5-HT1A, 5-HT2A receptors, 5-HT uptake sites and tryptophan hydroxylase activity in mature rat brain1.
    Kulikov A; Moreau X; Jeanningros R
    Neuroendocrinology; 1999 Jun; 69(6):453-9. PubMed ID: 10364698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of an interaction between sumatriptan and selective serotonin reuptake inhibitors.
    Leung M; Ong M
    Headache; 1995 Sep; 35(8):488-9. PubMed ID: 7591744
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin (5-HT) and migraine.
    Silberstein SD
    Headache; 1994; 34(7):408-17. PubMed ID: 7928325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin in migraine: theories, animal models and emerging therapies.
    Johnson KW; Phebus LA; Cohen ML
    Prog Drug Res; 1998; 51():219-44. PubMed ID: 9949863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilia myalgia syndrome. The role of contaminants, the role of serotonergic metabolism set up.
    Nicolodi M; Sicuteri F
    Adv Exp Med Biol; 1996; 398():351-7. PubMed ID: 8906288
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aggregation and 3H-serotonin release from thrombocytes stimulated by serotonin in patients with migraine].
    Pukhal'skaia TG; Kolosova OA; Men'shikov MIu
    Biull Eksp Biol Med; 1998 Aug; 126(8):156-9. PubMed ID: 9777225
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serotonin uptake inhibitors].
    Jiménez MD; Aguilera JM; Márquez C; Friera G
    Rev Neurol; 1995; 23 Suppl 2():S190-2. PubMed ID: 7497285
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulating the serotonin system in the treatment of major depressive disorder.
    Morrissette DA; Stahl SM
    CNS Spectr; 2014 Dec; 19 Suppl 1():57-67; quiz 54-7, 68. PubMed ID: 25544378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.